PL1778696T3 - Pochodne (1,10B-dihydro-2(aminokarbonylo-fenylo)-5H-pirazolo[1,5-C]benzoksazyno-5-ylo)fenylo metanonu jako inhibitory replikacji wirusa HIV - Google Patents

Pochodne (1,10B-dihydro-2(aminokarbonylo-fenylo)-5H-pirazolo[1,5-C]benzoksazyno-5-ylo)fenylo metanonu jako inhibitory replikacji wirusa HIV

Info

Publication number
PL1778696T3
PL1778696T3 PL05740229T PL05740229T PL1778696T3 PL 1778696 T3 PL1778696 T3 PL 1778696T3 PL 05740229 T PL05740229 T PL 05740229T PL 05740229 T PL05740229 T PL 05740229T PL 1778696 T3 PL1778696 T3 PL 1778696T3
Authority
PL
Poland
Prior art keywords
phenyl
benzoxazin
pyrazolo
aminocarbonyl
dihydro
Prior art date
Application number
PL05740229T
Other languages
English (en)
Inventor
Abdellah Tahri
Lieve Emma Jan Michiels
Acker Koenraad Lodewijk August Van
Dominique Louis Nestor Ghislain Surleraux
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of PL1778696T3 publication Critical patent/PL1778696T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL05740229T 2004-05-04 2005-05-04 Pochodne (1,10B-dihydro-2(aminokarbonylo-fenylo)-5H-pirazolo[1,5-C]benzoksazyno-5-ylo)fenylo metanonu jako inhibitory replikacji wirusa HIV PL1778696T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04101913 2004-05-04
US60427504P 2004-08-25 2004-08-25
EP05740229A EP1778696B1 (en) 2004-05-04 2005-05-04 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors
PCT/EP2005/052041 WO2005105810A2 (en) 2004-05-04 2005-05-04 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors

Publications (1)

Publication Number Publication Date
PL1778696T3 true PL1778696T3 (pl) 2008-08-29

Family

ID=35058129

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05740229T PL1778696T3 (pl) 2004-05-04 2005-05-04 Pochodne (1,10B-dihydro-2(aminokarbonylo-fenylo)-5H-pirazolo[1,5-C]benzoksazyno-5-ylo)fenylo metanonu jako inhibitory replikacji wirusa HIV

Country Status (20)

Country Link
US (1) US7326703B2 (pl)
EP (1) EP1778696B1 (pl)
JP (1) JP4929162B2 (pl)
KR (1) KR20070015547A (pl)
CN (1) CN1950380B (pl)
AP (1) AP2006003759A0 (pl)
AR (1) AR048650A1 (pl)
AT (1) ATE389660T1 (pl)
AU (1) AU2005238235B2 (pl)
BR (1) BRPI0510612A (pl)
CA (1) CA2563959C (pl)
DE (1) DE602005005490T2 (pl)
ES (1) ES2303244T3 (pl)
IL (1) IL178082A (pl)
MX (1) MXPA06012755A (pl)
NO (1) NO20065582L (pl)
PL (1) PL1778696T3 (pl)
RU (1) RU2382789C2 (pl)
WO (1) WO2005105810A2 (pl)
ZA (1) ZA200609178B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122185B2 (en) 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
TW200710091A (en) * 2005-04-11 2007-03-16 Tibotec Pharm Ltd (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
ES2438019T3 (es) * 2005-07-22 2014-01-15 Cytodyn, Inc. Procedimientos para reducir la carga viral en pacientes infectados por el VIH-1
JP2010531301A (ja) * 2007-06-25 2010-09-24 テイボテク・フアーマシユーチカルズ ダルナビル及びエトラビリンを含んでなる組み合わせ調剤
US8592487B2 (en) * 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
WO2009134401A2 (en) * 2008-04-29 2009-11-05 Progenics Pharmaceuticals, Inc. Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DE4210939A1 (de) * 1992-04-02 1993-10-07 Bayer Ag Verwendung von 7-Oxo-7H-pyrido[1,2,3-de][1,4]benzoxacin-6-carbonsäuren und -estern als Arzneimittel
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
PT721331E (pt) 1993-10-01 2002-05-31 Astrazeneca Ab Processo i
DK0904060T3 (da) 1996-05-20 2004-04-13 Janssen Pharmaceutica Nv Antifungale præparater med forbedret biotilgængelighed
CA2268953A1 (en) * 1996-10-02 1998-04-09 Du Pont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
PT969821E (pt) 1997-03-26 2003-10-31 Janssen Pharmaceutica Nv Pastilhas tendo um nucleo revestido com um antifungico e um polimero
WO1999059587A1 (en) * 1998-05-20 1999-11-25 Eli Lilly And Company Anti-viral compounds
AU2002242926B2 (en) * 2001-04-10 2007-10-11 Pfizer Inc. Pyrazole derivatives for treating HIV

Also Published As

Publication number Publication date
JP4929162B2 (ja) 2012-05-09
JP2007536346A (ja) 2007-12-13
AU2005238235A1 (en) 2005-11-10
ES2303244T3 (es) 2008-08-01
MXPA06012755A (es) 2007-01-16
IL178082A (en) 2012-06-28
RU2382789C2 (ru) 2010-02-27
AU2005238235B2 (en) 2011-07-07
EP1778696B1 (en) 2008-03-19
DE602005005490D1 (de) 2008-04-30
AP2006003759A0 (en) 2006-10-31
ZA200609178B (en) 2008-08-27
KR20070015547A (ko) 2007-02-05
ATE389660T1 (de) 2008-04-15
DE602005005490T2 (de) 2009-04-23
CA2563959C (en) 2014-07-15
CA2563959A1 (en) 2005-11-10
NO20065582L (no) 2006-12-04
CN1950380B (zh) 2010-12-08
CN1950380A (zh) 2007-04-18
WO2005105810A2 (en) 2005-11-10
WO2005105810A3 (en) 2006-03-02
AR048650A1 (es) 2006-05-10
RU2006142705A (ru) 2008-06-20
US7326703B2 (en) 2008-02-05
IL178082A0 (en) 2006-12-31
US20070248624A1 (en) 2007-10-25
BRPI0510612A (pt) 2007-10-30
EP1778696A2 (en) 2007-05-02

Similar Documents

Publication Publication Date Title
TWI349672B (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
EP2223921B8 (en) 2-Thiophen-2-yl-oxazole, 2-Thiophen-2-yl-thiazole and 2-Thiophen-2-yl-1H-imidazole derivatives as antiviral agents
AP2321A (en) Quinoline derivatives for use as mycobactrial inhibitor.
AP2005003353A0 (en) Diazepinoindole derivatives as kinase inhibitors.
ZA200705040B (en) 2,4 (4,6) pyrimidine derivatives
HK1093503A1 (en) Pyrido 2, 1-a-isoquinoline derivatives as ddp-IV inhibitors
ZA200700181B (en) Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors
HK1107348A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
SI1888580T1 (sl) Pirido d pirimidini uporabni kot inhibitorjiHCV in postopki za njihovo pripravo
GB0419481D0 (en) Isoindolin-1-one derivatives
IL172876A0 (en) Substituted arylthiourea derivatives useful as inhibitors of viral replication
IL182054A0 (en) Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
ZA200705027B (en) Phenyl-piperazin methanone derivatives
IL178082A0 (en) (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors
ZA200909132B (en) 6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile derivatives as cathepsin inhibitors
IL182739A0 (en) Acylatednonadepsipeptides used as lysobactin derivatives
HK1104823A1 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
HK1079984A1 (zh) 抑制hiv複製的甘氨酰胺衍生物
EP1786433A4 (en) BETULINOL DERIVATIVES AS ANTI-HIV MEDIUM
EP1797077A4 (en) BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND APPLICATIONS THEREOF
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
EP1711189A4 (en) AZALIDE DERIVATIVES 8A 6,11-3C-BICYCLIC
EP1781678A4 (en) 1 -? - HALOGEN-2,2-DIFLUOR-2-DESOXY-D-RIBOFURANOSEDERIVATE AND PROCESS FOR THE PRODUCTION THEREOF
AP2006003487A0 (en) Substituted arylthiourea derivatives useful as inhibitors of viral replication.